- In March 2024, MTD (Medical Technology and Devices) (Italy), acquired Ypsomed's pen needle and blood glucose monitoring (BGM) businesses. This strategic move will solidify MTD's position as a globally leading player in pen needle production and will enhance its comprehensive solution portfolio of diabetes care
